Emerging Biopharma

Worker bees in hive seen through honeycomb
Biotech

Beeline bolsters autoimmune ambitions with $126M

The funds come from existing backers Bain Capital, the Canada Pension Plan Investment Board and BMS, which also provided the biotech's five programs.
Darren Incorvaia Jun 30, 2026 7:00am
heart money

Merck KGaA pledges $50M to new biotech with eye to acquisition

Jun 23, 2026 10:16am
Sketch of lungs

With $30M, Oorja Bio breathes new life into fibrosis candidate

May 20, 2026 10:31am
Fierce 15 Hero

Nominations now open for Fierce Biotech's 2026 Fierce 15

May 18, 2026 9:44am
Constellation Orion

Oryon shines out of stealth with $21M to fight Parkinson's

Mar 23, 2026 5:00am
F1 Racetrack

R1 debuts with $77.5M to advance kidney disease treatment

Mar 17, 2026 7:00am
More News

Biotech unit Pfizer Ignite flames out

Mar 12, 2026 3:58pm

French biotech pens $128M deal for Kezar protein degrader work

Mar 12, 2026 9:00am

Atrium arises from Avidity buyout with $270M, preclinical assets

Feb 27, 2026 11:05am

Harbour sails with Solstice in $1.1B biobucks deal

Feb 24, 2026 2:38pm